Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions
Interventions
- BIOLOGICAL: anti-thymocyte globulin
- BIOLOGICAL: filgrastim
- BIOLOGICAL: graft-versus-tumor induction therapy
- BIOLOGICAL: rituximab
- DRUG: cyclophosphamide
- DRUG: cyclosporine
- DRUG: fludarabine phosphate
- DRUG: mycophenolate mofetil
- PROCEDURE: nonmyeloablative allogeneic hematopoietic stem cell transplantation
- RADIATION: total-body irradiation
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators